Cargando…
Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology
Cocaine use in clinical trials is often measured via self-report, which can be inaccurate, or urine drug screens, which can be intrusive and burdensome. Devices that can automatically detect cocaine use and can be worn conveniently in daily life may provide several benefits. AutoSense is a wearable,...
Autores principales: | Holtyn, August F., Bosworth, Eugene, Marsch, Lisa A., McLeman, Bethany, Meier, Andrea, Saunders, Elizabeth C., Ertin, Emre, Ullah, Md Azim, Samiei, Shahin Alan, Hossain, Monowar, Kumar, Santosh, Preston, Kenzie L., Vahabzadeh, Massoud, Shmueli-Blumberg, Dikla, Collins, Julia, McCormack, Jennifer, Ghitza, Udi E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582185/ https://www.ncbi.nlm.nih.gov/pubmed/31245651 http://dx.doi.org/10.1016/j.conctc.2019.100392 |
Ejemplares similares
-
An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches
por: Ertin, Emre, et al.
Publicado: (2021) -
NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research
por: Ghitza, Udi E., et al.
Publicado: (2015) -
A Note From NIDA’s Director
por: Volkow, Nora D.
Publicado: (2011) -
A Note From NIDA’s Director
por: Volkow, Nora D.
Publicado: (2004) -
A Note From NIDA’s Director
por: Volkow, Nora D.
Publicado: (2005)